2023
DOI: 10.1089/ten.teb.2022.0190
|View full text |Cite
|
Sign up to set email alerts
|

Cartilage Tissue Engineering in Practice: Preclinical Trials, Clinical Applications, and Prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 207 publications
0
1
0
Order By: Relevance
“…Although efforts had been made by plenty of researchers, very few materials could turn into effective biomedical products. Hence, the clinical transformation of a porous scaffold composed of biodegradable biomaterials for the regeneration of articular cartilage is still a challenge [63][64][65].…”
Section: Discussionmentioning
confidence: 99%
“…Although efforts had been made by plenty of researchers, very few materials could turn into effective biomedical products. Hence, the clinical transformation of a porous scaffold composed of biodegradable biomaterials for the regeneration of articular cartilage is still a challenge [63][64][65].…”
Section: Discussionmentioning
confidence: 99%
“…These methods, while displaying varying degrees of success, underline the challenges that persist in both the technical and regulatory domains of CTE. A comprehensive approach to resolving these challenges would inevitably necessitate both rigorous preclinical trials and detailed clinical evaluations to assess the effectiveness of these therapeutic strategies [18]. Thus, the intricate fabric of CTE is woven from multiple disciplinary threads, including biology, materials science, and engineering technology.…”
Section: Mechanical Regulation and Thermal Challengesmentioning
confidence: 99%
“…These constructs are meticulously designed to replicate the structural/compositional properties of native AC and provide an optimal environment for chondrocyte growth and ECM production [6]. Cartilage TE requires careful consideration regarding the scaffold material (natural or synthetic), scaffold type (e.g., 3D-printed structures, sponges, nanofibrous matrices, hydrogels), cell types (e.g., chondrocytes, MSCs) and growth factors/small molecules (e.g., transforming growth factor-β (TGF-β), kartogenin) to include [14][15][16][17]. Besides their capacity to differentiate into chondrocytes, MSCs are a promising source for cartilage TE strategies due to their high availability for isolation from several human tissues (e.g., adipose tissue, bone marrow, synovial membrane, umbilical cord), high in vitro proliferation capacity, low immunogenicity and favorable immunomodulatory/trophic properties [18][19][20].…”
Section: Introductionmentioning
confidence: 99%